Saturday, October 1, 2022 | Back issues
Courthouse News Service Courthouse News Service

Cancer Drug Antitrust

Merck, Cancer Research Technology, and Sanofi-Aventis manipulated the patent process and filed sham litigation to extend their monopoly over a brain cancer drug, Temodar, an antitrust class action claims in Delaware Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.